Skip to main content

Signalling and cellular heterogeneity in cancer - Marco Gerling, Leander Blaas, Rune Toftgård

Cancer is a complex disease.
Our group tackles tumor complexity from different angles, focusing on signaling pathways (Rune Toftgård), cellular heterogeneity (Leander Blaas) and cellular interactions (Marco Gerling) in cancer development and progression.